Internal Medicine, Cardiovascular Disease · Stuart, FL
NPI
1174583975
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1001 SE Monterey Commons Blvd, Suite 300
Stuart, FL, 34996
Phone (772) 286-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$980K
16,898 services
Medicare patients, 2024
4,908
Average age 78
Drug cost, 2024
$3.1M
13,791 prescriptions
Company payments, 2025
$617
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence H Mufson was code 99490 (chronic, principal, and transitional care management), 4,344 times for 559 patients. In total Lawrence H Mufson billed 16,898 services in 65 codes, and Medicare paid $980K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-01.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 4,344 | 559 | $51.06 | $222K |
| 99214 Office E&M - Established | Office | 3,495 | 1,991 | $97.04 | $339K |
| 93000 Electrocardiogram | Office | 2,401 | 1,694 | $11.13 | $27K |
| 93010 Electrocardiogram | Facility | 2,125 | 1,755 | $6.05 | $13K |
| 93793 Care Management/Coordination | Office | 691 | 38 | $8.51 | $5,877 |
| 93306 Echocardiography (TTE/TEE) | Office | 682 | 679 | $148.02 | $101K |
| 93296 External Electrocardiographic Monitoring | Office | 292 | 121 | $15.90 | $4,644 |
| 99215 Office E&M - Established | Office | 269 | 207 | $143.39 | $39K |
| 93306 Echocardiography (TTE/TEE) | Facility | 259 | 258 | $49.48 | $13K |
| 93294 External Electrocardiographic Monitoring | Office | 202 | 87 | $22.01 | $4,446 |
| 99233 Hospital E&M - Subsequent | Facility | 185 | 104 | $99.00 | $18K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 179 | 109 | $39.29 | $7,032 |
| 93298 External Electrocardiographic Monitoring | Office | 126 | 41 | $44.73 | $5,636 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 122 | 122 | $140.90 | $17K |
| 99204 Office E&M - New | Office | 121 | 121 | $125.10 | $15K |
By year: 2022 $675K for 10,050 services; 2023 $799K for 13,566 services; 2024 $980K for 16,898 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence H Mufson prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,165 prescriptions and refills. In total Lawrence H Mufson wrote 13,791 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,165 | 3,397 | 365 | $12K |
| Metoprolol Succinate Generic | 1,062 | 3,028 | 333 | $16K |
| Eliquis Apixaban | 1,027 | 2,229 | 267 | $1.3M |
| Rosuvastatin Calcium Generic | 1,023 | 3,034 | 363 | $16K |
| Losartan Potassium Generic | 1,020 | 2,968 | 338 | $11K |
| Amlodipine Besylate Generic | 941 | 2,723 | 297 | $6,908 |
| Ezetimibe Generic | 854 | 2,512 | 274 | $26K |
| Repatha Sureclick Evolocumab | 429 | 845 | 106 | $479K |
| Hydrochlorothiazide Generic | 419 | 1,153 | 128 | $2,437 |
| Lisinopril Generic | 413 | 1,199 | 130 | $3,594 |
| Furosemide Generic | 385 | 995 | 143 | $2,677 |
| Valsartan Generic | 327 | 936 | 113 | $12K |
| Hydralazine Hcl Generic | 311 | 771 | 102 | $5,330 |
| Metoprolol Tartrate Generic | 296 | 804 | 116 | $2,654 |
| Carvedilol Generic | 274 | 801 | 90 | $2,920 |
Brand drugs: 2,292 claims; generic drugs: 11,499 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence H Mufson $617 ($617 in general payments such as food, travel and fees) from 13 companies. The largest payer was Novartis Pharmaceuticals Corporation with $139.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 20 | $139 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $84.16 |
| Heartflow, Inc. HTFL | 1 | $68.34 |
| Amgen Inc. AMGN | 4 | $61.35 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $39.67 |
| Pfizer Inc. PFE | 2 | $38.04 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $37.95 |
| Merck Sharp & Dohme LLC MRK | 2 | $32.8 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $31.04 |
| Boston Scientific Corporation BSX | 1 | $26.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.